Trajectories of neutrophil-to-lymphocyte ratios during neoadjuvant chemotherapy correlate with short- and long-term outcomes in gastric cancer: a group-based trajectory analysis

Table 2 Odds Ratio (OR) of serious postoperative complications in the trajectory groups

	Unadjusted model		Preliminary adjusted model^a		Fully adjusted model^b
Higher CDC ratings	Odds Ratio (95% CI)	p value	Odds Ratio (95% CI)	p value	Odds Ratio (95% CI)	p value
Stable	Reference		Reference		Reference
Ascent-descend	0.747(0.333–1.680)	0.481	0.818(0.358–1.870)	0.634	0.820(0.337–1.997)	0.663
Continuous descent	2.400(1.083–5.319)	0.031	2.565(1.123–5.862)	0.025	3.660(1.392–9.622)	0.009

Note ^a Adjusted for age, gender, BMI, ECOG scoring scale
^b Additional adjusted for CT TNM stage, Tumor location, Resection range, Multiorgan resection (yes/no), Intraoperative blood loss, number of lymph node dissections, Lymphovascular invasion(yes/no), Neural infiltration (yes/no), Tumor regression grade, ypTNM stage

ISSN: 1471-2407